ARCHIVES

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

This article is from The Cancer Letter archive.

Vol. 27 No. 39 | October 26, 2001

Download PDF Visit The Full Archive

Related Articles

Senate “Pleased” About Reductions In Incidence And Mortality

October 8, 1999

Trial Links Potential Biomarkers To Drugs For Lung Cancer, To Help Target Therapies

April 30, 2010

Bill Would Improve Quality Of Care, Close Gaps in Services, Supporters Say. Sen. Arlen Specter to NIH Advocates: “Be More Politically Active;” Asks NCI For “A Winning Strategy.”

May 26, 2006

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

March 11, 2005